News | Atherectomy Devices | February 13, 2020

FDA Issues Final Guidance on Peripheral Vascular Atherectomy Devices

A CSI Diamondabck 360 atheretectomy system in use during a cath lab procedure at Henry Ford Hospital in Detroit. Photo by Dave Fornell

A CSI Diamondabck 360 atheretectomy system in use during a cath lab procedure at Henry Ford Hospital in Detroit. Photo by Dave Fornell


February 13, 2020 — The U.S. Food and Drug Administration (FDA) has issued its final guidance on "Peripheral Vascular Atherectomy Devices – Premarket Notification [510(k)] Submissions."

The guidance applies to atherectomy devices used in the peripheral vasculature, which are classified by the FDA as class II devices. Atherectomy devices used in coronary vasculature are outside the scope of this final guidance.

This guidance document provides recommendations for 510(k) submissions for peripheral artery disease (PAD) atherectomy devices. The FDA said the recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of peripheral vascular
atherectomy submissions.

This guidance is intended to help manufacturers evaluate their device, enhance consistency of performance testing, and promote the safe use of these devices in clinical settings.

Based on comments received on the draft guidance, the FDA said the final guidance includes additional clarifying details, including examples, about content related to corrosion testing, bench testing, and software. 

Read the FDA guidance documents

Related Content

News | Atherectomy Devices

July 28, 2022 — Northeast Scientific Inc., pioneers in reprocessing single use peripheral vascular catheters, announced ...

Home July 28, 2022
Home
News | Atherectomy Devices

March 9, 2022 — Medtronic is recalling (correcting) the TurboHawk Plus Directional Atherectomy System due to design ...

Home March 09, 2022
Home
News | Atherectomy Devices

January, 24, 2022 — Medtronic Inc. is recalling its HawkOne Directional Atherectomy System product due to the risk of ...

Home January 24, 2022
Home
News | Atherectomy Devices

January 10, 2022 — Cardiovascular Systems Inc. (CSI) is recalling the Wirion atherectomy embolic protection device ...

Home January 10, 2022
Home
News | Atherectomy Devices

July 20, 2020 – BD (Becton, Dickinson and Company) recently completed the acquisition of Straub Medical AG, a privately ...

Home July 20, 2020
Home
News | Atherectomy Devices

November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

Home November 11, 2019
Home
News | Atherectomy Devices

November 7, 2019 — There was no difference between drug-coated balloons (DCB) vs. plain old balloon angioplasty (POBA) ...

Home November 07, 2019
Home
Technology | Atherectomy Devices

September 13, 2019 — Rex Medical L.P. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for ...

Home September 13, 2019
Home
News | Atherectomy Devices

July 18, 2018 — Avinger Inc. announced in June that several physicians have successfully treated over 40 patients for ...

Home July 18, 2018
Home
Technology | Atherectomy Devices

May 24, 2018 — Avinger Inc. announced that the company received 510(k) clearance from the U.S. Food & Drug ...

Home May 24, 2018
Home
Subscribe Now